ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

The post Biogen (BIIB) breakout and retrace signals buying opportunity appeared on BitcoinEthereumNews.com. Shares of Biogen Inc. (BIIB) are showing signs of life. In 2021, this biotech company traded as high as $470. It currently trades near $140. Biotech and pharma are out of favor these days, but that may be changing. BIIB recently broke out of a major descending trendline. This trendline goes back to 2023 and has held price below since then. Biogen just broke above it three weeks ago, surging as $160. With a confirmed daily breakout, BIIB has retraced back to the ‘scene of the crime’. In technical analysis, this is the buy level investors wait for. In other words, this retrace offers investors a unique opportunity to buy a confirmed breakout, but back at the breakout trendline. While breakouts can fail, probability dictates BIIB should rally higher. The upside target could $190 per technical analysis. Source: https://www.fxstreet.com/news/biogen-biib-breakout-and-retrace-signals-buying-opportunity-202510201333The post Biogen (BIIB) breakout and retrace signals buying opportunity appeared on BitcoinEthereumNews.com. Shares of Biogen Inc. (BIIB) are showing signs of life. In 2021, this biotech company traded as high as $470. It currently trades near $140. Biotech and pharma are out of favor these days, but that may be changing. BIIB recently broke out of a major descending trendline. This trendline goes back to 2023 and has held price below since then. Biogen just broke above it three weeks ago, surging as $160. With a confirmed daily breakout, BIIB has retraced back to the ‘scene of the crime’. In technical analysis, this is the buy level investors wait for. In other words, this retrace offers investors a unique opportunity to buy a confirmed breakout, but back at the breakout trendline. While breakouts can fail, probability dictates BIIB should rally higher. The upside target could $190 per technical analysis. Source: https://www.fxstreet.com/news/biogen-biib-breakout-and-retrace-signals-buying-opportunity-202510201333

Biogen (BIIB) breakout and retrace signals buying opportunity

Author: BitcoinEthereumNews

Source: BitcoinEthereumNews

2025/10/21 00:11

COM$0.004175-1.39%

INC$0.8036-3.93%

LIFE$0.00003291-0.18%

NEAR$1.516-0.32%

Shares of Biogen Inc. (BIIB) are showing signs of life. In 2021, this biotech company traded as high as $470. It currently trades near $140. Biotech and pharma are out of favor these days, but that may be changing.

BIIB recently broke out of a major descending trendline. This trendline goes back to 2023 and has held price below since then. Biogen just broke above it three weeks ago, surging as $160. With a confirmed daily breakout, BIIB has retraced back to the ‘scene of the crime’.

In technical analysis, this is the buy level investors wait for. In other words, this retrace offers investors a unique opportunity to buy a confirmed breakout, but back at the breakout trendline. While breakouts can fail, probability dictates BIIB should rally higher. The upside target could $190 per technical analysis.

Source: https://www.fxstreet.com/news/biogen-biib-breakout-and-retrace-signals-buying-opportunity-202510201333

Market Opportunity

null Price(null)

----

USD

null (null) Live Price Chart

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.